The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice
- PMID: 3555105
- PMCID: PMC1899745
The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice
Abstract
The effects of various doses of cyclophosphamide and low-dose (15 rads) radiation upon the size of tumors caused by 10(4) Sarcoma I (SaI) cells was determined. In intact A/Jax (A/J) recipients, the effect of the two agents singly and in combination was found to be dependent especially upon the dosage of cyclophosphamide and the time of its administration in relation to tumor inoculation. In cell transfer experiments to adult thymectomized, lethally irradiated, bone-marrow-restored (ATxXBM) mice, the effects of cyclophosphamide and irradiation appeared to be either overlapping (low dosages of cyclophosphamide) or additive (dosages of cyclophosphamide greater than or equal to 50 mg/kg), suggesting that the two agents exert their influence in dissimilar fashion, perhaps by injuring different cell types with the same basic function. The most pronounced conjoint effects are seen when low dosages of cyclophosphamide are given 3 days after the adoptive transfer of spleen cells from mice pretreated with low-dose irradiation. The implications of this observation with respect to immunotherapy are discussed.
Similar articles
-
Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.Am J Pathol. 1982 Jul;108(1):24-38. Am J Pathol. 1982. PMID: 7046454 Free PMC article.
-
Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.J Clin Invest. 1998 Jan 15;101(2):429-41. doi: 10.1172/JCI1348. J Clin Invest. 1998. PMID: 9435316 Free PMC article.
-
Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors.Cancer Res. 1990 Apr 15;50(8):2228-33. Cancer Res. 1990. PMID: 2317810
-
Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.Isr J Med Sci. 1973 Mar;9(3):350-65. Isr J Med Sci. 1973. PMID: 4145461 Review. No abstract available.
-
The immunological network at the site of tumor rejection.Biochim Biophys Acta. 1986 Aug 5;865(1):1-11. doi: 10.1016/0304-419x(86)90009-0. Biochim Biophys Acta. 1986. PMID: 2942190 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources